Reduced Abundance of Butyrate-Producing Bacteria Species in the Fecal Microbial Community in Crohn's Disease
暂无分享,去创建一个
Makoto Fujii | Kenichiro Takahashi | O. Inatomi | A. Andoh | A. Nishida | S. Bamba | Kenichiro Takahashi | M. Sugimoto | Akira Andoh | Takehide Fujimoto | M. Fujii | M. Shioya | H. Imaeda | Shigeki Bamba | Mitsushige Sugimoto | Atsushi Nishida | Osamu Inatomi | Hirotsugu Imaeda | Takehide Fujimoto | Makoto Shioya
[1] F Kern,et al. Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study. , 1976, Gastroenterology.
[2] H. Flint,et al. Phylogenetic Relationships of Butyrate-Producing Bacteria from the Human Gut , 2000, Applied and Environmental Microbiology.
[3] M. Neurath,et al. Mouse models of inflammatory bowel disease. , 2007, Advanced drug delivery reviews.
[4] J. Doré,et al. Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients , 2008, Proceedings of the National Academy of Sciences.
[5] J. Berzofsky,et al. Commensal DNA limits regulatory T cell conversion and is a natural adjuvant of intestinal immune responses. , 2008, Immunity.
[6] Shunsuke Takahashi,et al. Development of a Prokaryotic Universal Primer for Simultaneous Analysis of Bacteria and Archaea Using Next-Generation Sequencing , 2014, PloS one.
[7] A. Kostic,et al. The microbiome in inflammatory bowel disease: current status and the future ahead. , 2014, Gastroenterology.
[8] R. Sartor,et al. The role of diet on intestinal microbiota metabolism: downstream impacts on host immune function and health, and therapeutic implications , 2014, Journal of Gastroenterology.
[9] N. Pace,et al. Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases , 2007, Proceedings of the National Academy of Sciences.
[10] J. Doré,et al. Dysbiosis of fecal microbiota in Crohn's disease patients as revealed by a custom phylogenetic microarray , 2010, Inflammatory bowel diseases.
[11] E. Mizoguchi,et al. Inflammatory bowel disease, past, present and future: lessons from animal models , 2008, Journal of Gastroenterology.
[12] P. Rutgeerts,et al. Faecal metabolite profiling identifies medium-chain fatty acids as discriminating compounds in IBD , 2014, Gut.
[13] C. Homer,et al. Digesting the genetics of inflammatory bowel disease: insights from studies of autophagy risk genes. , 2012, Inflammatory bowel diseases.
[14] J. Tiedje,et al. Naïve Bayesian Classifier for Rapid Assignment of rRNA Sequences into the New Bacterial Taxonomy , 2007, Applied and Environmental Microbiology.
[15] Judy H. Cho,et al. [Letters to Nature] , 1975, Nature.
[16] N. Pace,et al. Disease phenotype and genotype are associated with shifts in intestinal‐associated microbiota in inflammatory bowel diseases , 2011, Inflammatory bowel diseases.
[17] T. Matsui,et al. Multicenter analysis of fecal microbiota profiles in Japanese patients with Crohn’s disease , 2012, Journal of Gastroenterology.
[18] R Balfour Sartor,et al. Microbial influences in inflammatory bowel diseases. , 2008, Gastroenterology.
[19] Sarah L. Brown,et al. A key role for autophagy and the autophagy gene Atg16l1 in mouse and human intestinal Paneth cells , 2008, Nature.
[20] P. Lawson,et al. Reclassification of Clostridium coccoides, Ruminococcus hansenii, Ruminococcus hydrogenotrophicus, Ruminococcus luti, Ruminococcus productus and Ruminococcus schinkii as Blautia coccoides gen. nov., comb. nov., Blautia hansenii comb. nov., Blautia hydrogenotrophica comb. nov., Blautia luti comb. nov , 2008, International journal of systematic and evolutionary microbiology.
[21] H. Flint,et al. Proposal of Roseburia faecis sp. nov., Roseburia hominis sp. nov. and Roseburia inulinivorans sp. nov., based on isolates from human faeces. , 2006, International journal of systematic and evolutionary microbiology.
[22] Hata,et al. Counter‐regulatory effect of sodium butyrate on tumour necrosis factor‐alpha (TNF‐α)‐induced complement C3 and factor B biosynthesis in human intestinal epithelial cells , 1999, Clinical and experimental immunology.
[23] R. Sartor. The intestinal microbiota in inflammatory bowel diseases. , 2014, Nestle Nutrition Institute workshop series.
[24] Y. Benno,et al. Faecal microbiota profile of Crohn’s disease determined by terminal restriction fragment length polymorphism analysis , 2009, Alimentary pharmacology & therapeutics.
[25] A. Andoh,et al. Decreased abundance of Faecalibacterium prausnitzii in the gut microbiota of Crohn's disease , 2013, Journal of gastroenterology and hepatology.
[26] M. Tomita,et al. Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells , 2013, Nature.
[27] S. Lynch,et al. Role of the microbiota in inflammatory bowel diseases. , 2012, Inflammatory bowel diseases.
[28] F. Shanahan,et al. The microbiota in inflammatory bowel disease , 2015, Journal of Gastroenterology.